Number of grants | Dollars spent, US$ | Percent of COVID-19 funding, % | Percent of NIH annual funding, % | |
Social determinants of health | 278 | 188 229 016 | 8.52 | 0.42 |
Immunology | 211 | 570 461 693 | 25.82 | 1.26 |
Pharmaceutical interventions | 208 | 1 051 790 057 | 47.61 | 2.32 |
Impacts on other disease | 133 | 40 865 572 | 1.85 | 0.09 |
Diagnosis and testing | 132 | 186 846 477 | 8.46 | 0.41 |
Risk factor analysis | 111 | 55 501 547 | 2.51 | 0.12 |
Non-pharmaceutical interventions | 104 | 115 971 759 | 5.25 | 0.26 |
Paediatric health | 92 | 63 635 942 | 2.88 | 0.14 |
Transmission | 83 | 77 675 659 | 3.52 | 0.17 |
Other research | 83 | 515 823 132 | 23.35 | 1.14 |
Virology | 79 | 33 601 202 | 1.52 | 0.07 |
Geriatric health | 68 | 467 815 039 | 21.17 | 1.03 |
Neurology | 64 | 21 705 014 | 0.98 | 0.05 |
Pulmonology | 61 | 37 068 124 | 1.68 | 0.08 |
Maternal health | 41 | 19 633 841 | 0.89 | 0.04 |
Gastroenterology | 31 | 12 081 004 | 0.55 | 0.03 |
Cardiology | 18 | 32 997 172 | 1.49 | 0.07 |
Nephrology | 14 | 8 386 775 | 0.38 | 0.02 |
*Each grant can have multiple areas.